SHIVOM - CHANGE OF THE HEALTH WORLD

Hasil gambar untuk shivom bounty

The world of healthcare is changing. Two revolutionary technologies, genomics, and blockchain, are poised to significantly improve health and well-being across the globe. Genomic medicine can enhance the understanding and treatment of as many as 7,000 rare diseases, alongside cancers, complex and long-term disease such as cardiovascular and neurodegenerative conditions, and infections. Likewise, blockchain technology will transform both the future of healthcare and the world economy: it is poised to herald the biggest transformation in innovation since the advent of the internet and web 2.0. Shivom is the next evolutionary step in this development, bringing these technologies together to create a revolutionary medical genomics ecosystem that will open up healthcare opportunities for all.

Shivom offers the first ever integrated solution for patients and genome data donors where everybody will be able to have their genome sequenced and securely stored. This ecosystem will provide an open web-marketplace for other providers such as pharmaceuticals, research organizations, governments, patient-support groups and insurance companies to add their apps and services, alongside genomic data analytics and personalized medicine.

The global Shivom platform works on principles of collaboration, openness, integrity, security, and informed choice. 

We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a first-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology. We will additionally build a state-of-the art and not-for-profit drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe. Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication. Blockchain can also manage complex data rights and allow finegrained access using smart contracts.

WHY SHOULD YOU CHOOSE SHIVOM? 

To make the direct-to-consumer business more open, fair, and beneficial to all users, the Shivom platform uses blockchain technology to create a disruptive genomics ecosystem. It ensures data is owned by the data donors themselves. It ensures a transparent and secure bridge to organizations interested in using that data. 
  • Genome data donors own their data and access rights 
  • Donors gain rewards for sharing their genomic data on the blockchain by selling access rights directly to third party institutions such as pharmaceutical companies 
  • Pharmaceutical companies use the Shivom platform to refine drug development 
  • Shivom users have full and fine-grained control of who can access the data even after a third party institution has had access to it 
  • Patients get personalized health, well-being, and lifestyle information 
  • A dynamic ecosystem is created and continuously refined in which the community can identify and remove potential health roadblocks before they become serious

Stakeholder Structure:
Using permission-based smart-contracts, access to genomic information will be authorized by the blockchain while potential incentivization to the user or donor remains secure and anonymized.  




Blockchain technology helps users transmit genomic data or quantifiable lifestyle information to other stakeholders. At the same time, the patient can keep sensitive information, such as substance abuse data, hidden from certain stakeholders. As a result, outcomes of research and precision medicine initiatives can be better supported. In addition, this framework allows stakeholders to incentivize their client’s lifestyle change. For example, an insurer could offer to pay for a client to have his genome sequenced.



TOPLINE NUMBERS
Global healthcare market USD$ 8.7 trillion by 2020
Deloitte 2017 global healthcare sector outlook Precision medicine market USD$ 40 billion by end of 2016 CAGR 10-11% by 2025 — expected to reach up to 112.6 billion. This includes big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and more.

Hasil gambar untuk shivom bounty

ROADMAP

Gambar terkait


MORE INFORMATION : 

| WIBESITE | TELEGRAM | TWITTER |

| FACEBOOK | WHITEPAPER |

Komentar

Postingan populer dari blog ini

Sprintx - is a platform for entrepreneurs and the development of new business ideas

ZYPCOIN Innovative Connection Platform

LICERIO